# Blaize Holdings, Inc.: overview

BZAI · Nasdaq · CIK 1871638 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bzai.md) · [Financials](/companies/bzai/financials.md) · [Filings](/companies/bzai/filings.md) · [Insiders](/companies/bzai/insiders.md)

Latest reported revenue: [$12.0m](/filings/0001871638-26-000046.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001871638-26-000046).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.8](/filings/0001193125-25-280252.md) | [0.0 d](/filings/0001871638-26-000011.md) | [1.0](/filings/0001871638-26-000035.md) | [2.0](/filings/0001871638-26-000046.md) | [11.9](/filings/0001193125-25-280252.md) | [23.8 d](/filings/0001871638-26-000011.md) | [2.7](/filings/0001871638-26-000035.md) | [12.0](/filings/0001871638-26-000046.md) |
| Gross margin | % | [39.1%](/filings/0001193125-25-280252.md) | [46100.0% d](/filings/0001871638-26-000011.md) | [67.5%](/filings/0001871638-26-000035.md) | [59.4%](/filings/0001871638-26-000046.md) | [15.0%](/filings/0001193125-25-280252.md) | [10.8% d](/filings/0001871638-26-000011.md) | [57.6%](/filings/0001871638-26-000035.md) | [7.7%](/filings/0001871638-26-000046.md) |
| Operating margin | % | [(1455.6%)](/filings/0001193125-25-280252.md) | [(1699500.0%) d](/filings/0001871638-26-000011.md) | [(3775.7%)](/filings/0001871638-26-000035.md) | [(1104.1%)](/filings/0001871638-26-000046.md) | [(190.3%)](/filings/0001193125-25-280252.md) | [(89.8%) d](/filings/0001871638-26-000011.md) | [(854.2%)](/filings/0001871638-26-000035.md) | [(255.4%)](/filings/0001871638-26-000046.md) |
| Net margin | % | [(3278.7%)](/filings/0001193125-25-280252.md) | [(669200.0%) d](/filings/0001871638-26-000011.md) | [(14673.4%)](/filings/0001871638-26-000035.md) | [(1492.9%)](/filings/0001871638-26-000046.md) | [(221.3%)](/filings/0001193125-25-280252.md) | [(13.9%) d](/filings/0001871638-26-000011.md) | [(827.4%)](/filings/0001871638-26-000035.md) | [(240.4%)](/filings/0001871638-26-000046.md) |
| Diluted EPS | $ per share | [(1.47)](/filings/0001193125-25-280252.md) | not reported | [(1.61)](/filings/0001871638-26-000035.md) | [(0.28)](/filings/0001871638-26-000046.md) | [(0.25)](/filings/0001193125-25-280252.md) | not reported | [(0.19)](/filings/0001871638-26-000035.md) | [(0.21)](/filings/0001871638-26-000046.md) |
| Free cash flow | $m | [(15.2) d](/filings/0001193125-25-280252.md) | [(18.0) d](/filings/0001871638-26-000011.md) | [(16.6)](/filings/0001871638-26-000035.md) | [(16.4) d](/filings/0001871638-26-000046.md) | [(24.9) d](/filings/0001193125-25-280252.md) | [(16.5) d](/filings/0001871638-26-000011.md) | [(12.7)](/filings/0001871638-26-000035.md) | [(29.2) d](/filings/0001871638-26-000046.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | [1.6](/filings/0001871638-26-000011.md) | [38.6](/filings/0001871638-26-000011.md) |
| Gross margin | % | not reported | not reported | [62.7%](/filings/0001871638-26-000011.md) | [16.0%](/filings/0001871638-26-000011.md) |
| Operating margin | % | not reported | not reported | [(3065.3%)](/filings/0001871638-26-000011.md) | [(268.8%)](/filings/0001871638-26-000011.md) |
| Net margin | % | not reported | not reported | [(3937.9%)](/filings/0001871638-26-000011.md) | [(535.6%)](/filings/0001871638-26-000011.md) |
| Diluted EPS | $ per share | not reported | not reported | [(3.50)](/filings/0001871638-26-000011.md) | [(1.98)](/filings/0001871638-26-000011.md) |
| Free cash flow | $m | not reported | not reported | [(54.4)](/filings/0001871638-26-000011.md) | [(74.5)](/filings/0001871638-26-000011.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/bzai/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $10.2m | 7,387,308 |  | Added +1,742,482 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $6.4m | 4,654,065 |  | Added +1,069,738 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $2.9m | 2,136,932 |  | Added +362,338 |
| [LAZARD ASSET MANAGEMENT LLC](/funds/1207017.md) | 2026-06-30 | $2.7m | 1,986,835 |  | Added +782,631 |
| [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $2.5m | 1,807,978 |  | Added +265,504 |
| [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $2.2m | 1,607,810 |  | New +1,607,810 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.2m | 1,572,428 |  | Added +192,920 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $2.1m | 1,501,041 |  | Added +289,598 |
| [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $1.7m | 1,247,768 |  | Added +1,170,785 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](/funds/1446194.md) | 2026-06-30 | $1.5m | 1,079,100 | Call | Added +598,600 |

## Recent filings

[All 316 filings](/companies/bzai/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-22 | 16:35 ET | [8-K](/filings/0001871638-26-000081.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001871638-26-000081 |
| 2026-10-06 | 20:32 ET | [8-K](/filings/0001871638-26-000063.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001871638-26-000063 |
| 2026-10-02 | 16:30 ET | [8-K](/filings/0001871638-26-000059.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001871638-26-000059 |
| 2026-09-30 | 16:36 ET | [8-K](/filings/0001871638-26-000057.md) | 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001871638-26-000057 |
| 2026-09-18 | 16:01 ET | [SCHEDULE 13D/A](/filings/0001213900-26-101399.md) | Ownership report, active investor, amended | 0001213900-26-101399 |
| 2026-08-13 | 16:23 ET | [10-Q](/filings/0001871638-26-000046.md) | Quarterly report, period 2026-06-30 | 0001871638-26-000046 |
| 2026-08-13 | 16:17 ET | [8-K](/filings/0001871638-26-000044.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001871638-26-000044 |
| 2026-08-04 | 20:13 ET | [SCHEDULE 13D/A](/filings/0002048309-26-000007.md) | Ownership report, active investor, amended | 0002048309-26-000007 |
| 2026-07-09 | 17:19 ET | [SCHEDULE 13D/A](/filings/0001213900-26-076794.md) | Ownership report, active investor, amended | 0001213900-26-076794 |
| 2026-07-09 | 16:16 ET | [8-K](/filings/0001871638-26-000037.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001871638-26-000037 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001871638-26-000011.md), filed Mar 24, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1871638
- Tickers: BZAI, BZAIW
- Exchange: Nasdaq
- SIC code: 3674 Semiconductors & Related Devices
- State of incorporation: DE
- Filer category: <br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 17:31 ET. No prices; not investment advice.